Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Quarterly results
Insys Therapeutics, Inc. (INSY) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/11/2020 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
02/11/2020 8-K Quarterly results
02/10/2020 8-K Quarterly results
02/05/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Second Amendment to Transition Services Agreement, by and between Benuvia Therapeutics Inc. and Insys Therapeutics, Inc"
01/17/2020 8-K Regulation FD Disclosure
01/10/2020 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Second Plan Supplement Pursuant to the Second Amended Joint Chapter 11 Plan of Liquidation of Insys Therapeutics, Inc. and Its Affiliated Debtors, filed with the United States Bankruptcy Court for the District of Delaware"
01/03/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/03/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/03/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/03/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/03/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/26/2019 8-K Quarterly results
12/03/2019 8-K Entry into a Material Definitive Agreement, Changes in Registrant's Certifying Accountant, Regulation FD Disclosure, Financia...
Docs: "Asset Purchase Agreement, by and between Renaissance Lakewood, LLC and Insys Therapeutics, Inc",
"Letter from BDO USA, LLP",
"Second Amended Joint Chapter 11 Plan of Liquidation of Insys Therapeutics, Inc. and Its Affiliated Debtors",
"Disclosure Statement for Second Amended Joint Chapter 11 Plan of Liquidation of Insys Therapeutics, Inc. and Its Affiliated Debtors"
11/25/2019 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
11/20/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Amended Joint Chapter 11 Plan of Liquidation of Insys Therapeutics, Inc. and Its Affiliated Debtors",
"Disclosure Statement for Amended Joint Chapter 11 Plan of Liquidation of Insys Therapeutics, Inc. and Its Affiliated Debtors"
11/19/2019 SC 13G ETF MANAGERS GROUP, LLC reports a 0% stake in Insys Therapeutics Inc.
11/04/2019 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Transition Services Agreement, by and between Chilion Group Holdings US, Inc. and Insys Therapeutics, Inc",
"Monthly Operating Report, for the period covering September 1, 2019 through September 30, 2019, filed with the United States Bankruptcy Court for the District of Delaware"
10/25/2019 8-K Quarterly results
10/02/2019 8-K Quarterly results
09/27/2019 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
09/26/2019 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "ASSET PURCHASE AGREEMENT BETWEEN PHARMBIO KOREA, INC. AND INSYS THERAPEUTICS, INC. DATED AS OF SEPTEMBER 25, 2019"
09/17/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Joint Chapter 11 Plan of Liquidation of Insys Therapeutics, Inc. and Its Affiliated Debtors",
"Disclosure Statement for Joint Chapter 11 Plan of Liquidation of Insys Therapeutics, Inc. and Its Affiliated Debtors"
09/09/2019 8-K Quarterly results
09/03/2019 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "ASSET PURCHASE AGREEMENT BETWEEN BTcP PHARMA, LLC, AND INSYS THERAPEUTICS, INC. DATED AS OF September 1, 2019"
08/29/2019 8-K Other Events
08/13/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Monthly Operating Report, for the period covering June 10, 2019 through June 30, 2019, filed with the United States Bankruptcy Court for the District of Delaware"
08/08/2019 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/08/2019 8-K Quarterly results
07/19/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Initial Monthly Operating Report filed with the United States Bankruptcy Court for the District of Delaware"
07/15/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/24/2019 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
06/10/2019 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
06/10/2019 8-K Bankruptcy or Receivership, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "INSYS Therapeutics Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy Liabilities Company to Facilitate Transaction Process and Sale of Substantially All Assets Through Chapter 11 of the U.S. Bankruptcy Code"
06/10/2019 GN INSYS Therapeutics Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy Liabilities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy